Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Design|November 30, 2007
The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicityBenedict C AlbensiDrug News & Perspectives|September 16, 2003
A comparison of drug treatment versus electrical stimulation for suppressing seizure activityBenedict C AlbensiDrug News & Perspectives|April 5, 2003
Tumor Necrosis Factor and Drug Delivery in the Blood-Brain BarrierBenedict C. AlbensiExpert Opinion on Drug Discovery|March 20, 2013
Can in vitro assessment provide relevant end points for cognitive drug programs?Benedict C AlbensiFrontiers in Cell and Developmental Biology|August 27, 2019
What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?Benedict C AlbensiDrug News & Perspectives|April 5, 2003
Biological Mechanisms, Cerebrovascular Alterations and Pharmacological Targets in the Pathology of DementiaBenedict C. AlbensiInternational Review of Neurobiology|June 19, 2019
Dysfunction of mitochondria: Implications for Alzheimer's diseaseBenedict C AlbensiCells|May 27, 2026
Targeting Mitochondrial Dysfunction in Alzheimer's Disease Neurons: Lithium Boosts Oxidative PhosphorylationBenedict C Albensi, Aida AdlimoghaddamFrontiers in Aging Neuroscience|May 15, 2023
Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer's disease?Sophia Mirkin, Benedict C AlbensiDrug News & Perspectives|January 13, 2005
Open-channel blockers of the NMDA receptor complexBenedict C Albensi, Erin IlkanichPageof 8